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Evaluation of cold storage conditions for vessels
obtained from donor rats after cardiac death
Annette Ebner, PhD, Birgit Zatschler, and Andreas Deussen, MD, PhD, Dresden, Germany
Objective: To improve the availability of vessel grafts for allotransplantation, the current experimental study was designed
to first investigate the function of vessels obtained from non-heartbeating donor rats at various time points postmortem;
second, to assess the sensitivity of vessels recovered after circulatory arrest toward prolonged cold storage; and third, to
determine vessel function following cold storage with antimicrobial additives.
Methods:We investigated vessel tone development and endothelium-dependent and endothelium-independent relaxations
in aMulvanymyograph of aorta and saphenous artery sampled up to 24 hours after circulatory arrest. Additionally, tissue
reductive capacity and lactate dehydrogenase release were measured.
Results: Vessels recovered 2 hours postmortem showed similar results as controls recovered without delay. Vessels
recovered 6 hours or more after circulatory arrest showed reduced vessel tone development (ie, aorta): response to
potassium <15% and response to norepinephrine <25% of vessels recovered without delay; A. saphena response to
potassium: <12% and response to norepinephrine <10% of control vessels recovered without delay. All vessels recovered
after circulatory arrest showed a similar cold storage sensitivity as controls, with exception of a decreased endothelial
function of A. saphena harvested 6 hours postmortem (one-third response of non-stored control vessels). Treatment of
vessels recovered immediately or after circulatory arrest with gentamycin, piperacillin, and metronidazole as additives to
the optimized cold storage solution did not alter vessel function. Flucloxacillin as a cold storage additive reduced vessel
tone development in aorta but not in A. saphena. Addition of amphotericin B to the storage solution completely abolished
any vessel function and impaired tissue reductive capacity despite presence of radical scavengers.
Conclusions: The use of vessels from non-heartbeating donors in general and subsequent prolonged cold storage seems
feasible when vessels are recovered within 2 hours. The use of antibiotics needs to be carefully assessed for each
intended-to-use tissue. For vessels tested, a combination of gentamycin, piperacillin, and metronidazole supported the
maintenance of vessel function. (J Vasc Surg 2011;54:1769-77.)
Clinical Relevance:Vessel allograft transplantation is an option after vascular prosthesis infection with promising survival
rates and low reinfection rates. It is rarely used due to the limited availability of suitable grafts. Use of grafts recovered
from non-heartbeating donors (as done for bone and tendon grafting) might increase the number. However, maintaining
vessel physiological function and documenting tissue sterility require sophisticated procedures. Consequent standard-
ization of tissue storage and procurement seem necessary to fulfill legal requirements. The current experimental study
provides a first outline with respect to standardization of tissue sampling, cold storage, and antimicrobial treatment.
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tVascular prosthesis infection occurs rarely (0.6%-3%),
but its outcome is often devastating. Infection of an artifi-
cial vessel graft can result in functional disorder, loss of
limb, or death (mortality rate, 25%-88%).1 Typical treat-
ment options are conservative treatment with antibiotics,
rifampicin-bonded protheses, extra-anatomic bypass, and
replacement by autologous veins or allografts.2 Allografts
show a very low reinfection rate and good survival rates.3
However, the availability of human allografts for transplan-
tation purposes is highly limited.4 Whereas for other tissues
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doi:10.1016/j.jvs.2011.06.080eg, bone,5 skin, heart valve, and musculoskeletal grafts6),
issues obtained from deceased donors are frequently used,
his option has not been used for vessels in Europe. Most
otably, it is currently completely unclear whether vessel
ecovery postmortem does influence the graft function and
hether such vessels are more sensitive to cold storage
amage or whether they may serve as a transplant option
ith good success.
Besides difficulties in the recruitment process, mainte-
ance of vessel physiological function and the documenta-
ion of tissue sterility are major obstacles of vessel banking
nd transplant distribution. Following European guidelines
guidelines 2004/23/EG; 2006/17/EG), testing of tis-
ue microbial contamination is required by the German
issue law (issued July 20, 2007) before a tissue may be
onsidered for distribution. In the U.S., the proper han-
ling of tissue grafts according to Food and Drug Admin-
stration (FDA) guidelines does currently not require tissue
terility (issued November 24, 2004). However, this may
pply in the future, following technological progress en-
bling viral clearance or tissue sterility. With respect to
issue sterility, approximately 20% of vessel grafts are in-
ected by different microorganisms when no additional
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December 20111770 Ebner et aldecontamination is performed.7 Documented contami-
nants were mostly staphylococci and others like strepto-
cocci, Klebsiella, Escherichia coli, pseudomonas, and Propi-
onibacter acne. Similar results were found for bone,8 heart,
skin, and musculoskeletal tissues obtained from deceased
donors.6
Long-term cold storage of vessels is currently not per-
formed in Germany because there is no storage solution
available that allows long-term protection. A currently de-
veloped optimized solution 9 permits the cold storage of
freshly isolated human mammary arteries,10 rat aorta, and
mesenteric artery11 for up to 10 days without loss of vessel
function. Maintenance of vessel function, and in particular
endothelial cell function, seems important because endo-
thelial injury during storage may promote postoperative
graft vasculopathy and cause low reperfusion flow.12
The current experimental study was designed to inves-
tigate the function of vessels sampled from donor rats at
various time points after cardiac death and after different
periods of cold storage. Vasomotor function was used as a
measure of vessel viability. Thus, we first assessed endothe-
lial and smooth muscle function of isolated graft vessels
obtained immediately after circulatory arrest and after up to
24 hours postmortem. Secondly, the combined effects of
delayed vessel explantation and prolonged cold storage
were tested. Furthermore, it has been shown for vessels that
a higher percentage of grafts obtained from deceased do-
nors is infected compared with those from heartbeating
donors.7 Therefore, antimicrobial treatment might be ad-
vised during long-term cold storage. Although the antimi-
crobial effects of the substances used in this study are
unquestioned, no critical functional testing has been per-
formed with respect to the tissue considered for transplan-
tation. Therefore, a third aim of the present study was to
assess the effects of these antimicrobial additives on endo-
thelial and smooth muscle function of vessel grafts.
METHODS
The experimental project was approved by the Univer-
sity Commission on Animal Experiments with respect to
the animal welfare regulations of Germany, which conform
to National Institutes of Health Guidelines. Consecutively,
a written permission for the study was obtained from the
local authorities (24-9168.24-1/2009-16).
Animals and storage groups. Male Wistar rats
(Charles River Laboratories, Sulzfeld, Germany) were
killed by carbon dioxide exposure and cutting of the spinal
cord at the upper cervical level. Animals were either dis-
sected immediately or placed in a styropore box at room
temperature (21°C) for 2, 6, or 24 hours. Arteria saphena
(equivalent to human A. femoralis) and aorta thoracalis
(without aortic arch) were recovered and directly placed in
ice-cooled storage solution (TiProtec; Dr F. Köhler
GmbH, Bensheim, Germany) and stored for 2 hours, 96
hours (4 days), 168 hours (7 days), or 336 hours (14 days)
at 4°C. These two vessel types were chosen because the
aorta is an elastic type artery and A. saphena is a muscular
type artery. For testing the effects of antibiotics and antimy- notics, vessels were recovered either directly or 2 and 6 hours
ostmortem. Vessel segments of 5 mm to 15 mm length were
tored at 4°C in TiProtec storage solution augmented with the
ntibiotics gentamycin (40 g/mL, Refobacin; Merck, Darm-
tadt, Germany), piperacillin (1 mg/mL, Ratiopharm, Ger-
any), flucloxacillin (1 mg/mL, staphylex; Smith-Kline-
eecham Pharma GmbH, Mu¨nchen, Germany) metro-
idazole (200 g/mL; DeltaSelect GmbH, Pfullingen,
ermany), or the antimycotic amphotericin B (100 g/
L, Fungizone; Bristol-Myers Squibb, Agen, France) for
ither 4 or 7 days.
Following cold storage at 4°C, vessel segments were
ransferred to phosphate-buffered saline solution (PSS;
ontaining 119 mmol/L NaCl; 4.7 mmol/L KCl; 1.17
mol/L MgSO4; 1.18 mmol/L KH2PO4; 25 mmol/L
aHCO3; 5.5 mmol/L glucose; 0.027 mmol/L EDTA
odium salt; 2.5 mmol/L CaCl2), gently warmed to 37°C
ver 30 minutes, and subjected to function testing by
sometric force measurement (assessment of vessel tone) or
eductive capacity measurements.
Isometric force measurement. Vessel function was
easured in a myograph (DMT-610M, Power Laboratory/
00; A D-Instruments, Spechbach, Germany) according to
he method of Mulvany13 as previously described in de-
ail.11,14 In brief, aortic vessel rings (2051  19 m inter-
al width) were studied, stretched with a resting tension
quivalent to that obtained by exposure to an intraluminal
ressure of 30 mm Hg for maximal responses. For A.
aphena, rings with an internal diameter of 684  11 m
ere used, stretched with a resting tension equivalent to
hat obtained by exposure to an intraluminal pressure of
00 mmHg. Vessel rings were equilibrated for 10 minutes
rior to vasomotor analysis. Maximum contraction was
nduced by exposure of vessel rings to a potassium-enriched
olution (123.7 mmol/L KCl). Vessel tone development
as measured as contractile response to a single application
f 10 mol/L norepinephrine. Vessel relaxation toward
cetylcholine (ACH; 109.0- to 104.5 mol/L) and so-
ium nitroprusside (SNP; 109.0104.0 mol/L) was
ested after constriction induced by 10 mol/L norepi-
ephrine to assess endothelium-dependent and -indepen-
ent relaxations, respectively. For testing the effects of
ntibiotics on aorta, preconstriction was induced by 3
mol/L norepinephrine, because this lower concentration
roved superior for aorta with respect to reproducible
elaxation.
Reductive capacity. Vessels stored as described above
ere studied. To assess mitochondrial reductive capacity,
e used an alamar blue assay as described previously.10 The
ntra-assay coefficient of variation was 0.23. Total reductive
apacity is given in picomoles reduced resazurin per minute
ncubation time.
Vitality measurements. Cumulatively released lactate
ehydrogenase (LDH) activity was assessed as a parameter
f cell integrity. Supernatants of vessel segments stored for
eductive capacity measurements were measured with a
ommercially available cytotoxicity kit from Roche Diag-
ostics (Mannheim, Germany). To assess enzyme activity,
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Volume 54, Number 6 Ebner et al 1771external calibration was performed with lactate dehydroge-
nase from porcine heart (Sigma, Schnelldorf, Germany). A
linear relationship was found between 1 and 25 U with the
given substrate conditions. Samples with LDH activities
above this range were diluted with respective storage solu-
tions and quantified again. The intra-assay coefficient of
variation was 0.014. To eliminate interassay variations,
external calibration was performed on each plate.
Data analysis and statistics. Vascular tone was calcu-
lated as described previously and is given as developed force
relative to wall length.13 Maximum relaxation was ex-
pressed as percent of norepinephrine constriction.11 Data
are presented as mean values  their standard errors. Data
was analyzed for normal distribution with Kolmogorov-
Smirnov test. Homogeneity of variances was assessed ac-
cording to Levene. Intergroup differences were tested us-
ing one-way analysis of variance. Differences were assessed
with post-hoc multiple comparisons according to Dunnett
t test for comparing vessels recovered postmortem against
vessels recovered immediately after circulatory arrest (post-
mortem control) and for testing various storage conditions
(eg, antibiotic treatment vs no antibiotic treatment [storage
control]). A probability of P  .05 or less (two-sided) was
taken to indicate a significant difference. Data analysis was
performed using SPSS program version 11.5 (SPSS Inc,
Chicago, Ill).
RESULTS
Tone development of vessels recovered after cardiac
death. When vessels were recovered immediately after cir-
culatory arrest (postmortem control), and myograph mea-
Fig 1. Vessel tone development in response to norepine
after circulatory arrest (0 hours, 2 hours, and 6 hours: n
durations (2-336 hours). Left panel: rat A. saphena (e
Postmortem.surements occurred within 2 hours, vessel tone develop- aent of A. saphena and aorta in response to norepinephrine
as 5.43  0.55 mN/mm and 4.50  0.41 mN/mm,
espectively. This response was stable for up to 2 weeks of
old storage in A. saphena and for 4 days in aorta (Fig 1). In
ontrast, aortic vessel tone development was significantly
P  .004) suppressed following 1 week of cold storage.
fter 2 weeks of cold storage, none of five tested aortae
eveloped a vessel tone above 0.5 mN/mm (ie, 11% of
nitial tone), indicating severe impairment of contractile
unction.
A. saphena and aorta recovered 2 hours after circulatory
rrest developed a similar vessel tone as compared with
ontrol vessels and recovered without delay throughout the
nvestigated 2-week period. All vessels isolated 6 hours
ostmortem generally showed a significantly reduced vessel
one development in response to norephinephrine com-
ared with postmortem control vessels stored for an iden-
ical period of time. A. saphena isolated 24 hours post-
ortem did not show any residual vessel function.
imultaneously isolated aorta developed some residual
essel tone after 7 days of cold storage, ranging from 0.2
o 0.5 mN/mm. Similar results were obtained for analysis
f potassium-induced vessel tone development (Fig S1,
nline only).
Without a proper baseline, vessel tone development
n response to norepinephrine (above 0.5 mN/mm)
elaxation parameters could not be assessed for method-
cal reasons. Therefore, the 24-hours postmortem sam-
ling group for both vessels and the 2-week cold storage
ata for aortae were excluded from further relaxation
e (NE). Vessels were recovered at different time points
4 hours: n 3) with subsequent cold storage for various
lent to human A. femoralis). Right panel: aorta. pm,phrin
5; 2
quivanalysis.
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December 20111772 Ebner et alEndothelium-independent relaxations of vessels re-
covered after cardiac death. Endothelium-independent
relaxation was assessed using nitroprusside. For prolonged
cold storage (2 weeks for A. saphena; 1 week for aorta), this
maximum relaxation remained unchanged. Vessels recov-
ered 2 or 6 hours after circulatory arrest showed similar
smooth muscle relaxation for all examined cold storage
time points (Figs S2 and S3, online only).
Endothelium-dependent relaxation of vessels re-
covered after cardiac death. Endothelium-dependent re-
laxation was assessed as dilatative response to ACH. Con-
trol A. saphena showed a maximum relaxation of 37% 4%
(Fig 2, left panel). Control aorta showed a more pro-
nounced dilatative response to ACH with 92%  18% (Fig
2, right panel). For both vessels, percent maximum relax-
ation was not significantly altered by cold storage during
the evaluated storage periods.
Vessels recovered from deceased donors 2 and 6 hours
after circulatory arrest showed similar maximal responses
toward ACH as compared with their respective postmor-
tem control. Following prolonged cold storage at 4°C for
4, 7, and 14 days, A. saphena recovered 6 hours postmor-
tem showed a significantly reduced maximum relaxation
toward ACH (Fig 2). Endothelial function of aortae recov-
ered 2 or 6 hours postmortem were similar to controls.
Reductive capacity of vessels recovered after cardiac
death. Reductive capacity was assessed as resazurin reduc-
tion to check whether the cold storage solution does pro-
tect postmortem recovered vessels from storage injury.
Fig 2. Endothelium-dependent relaxation capacity of ve
(0 hours, 2 hours, and 6 hours: n  5; 24 hours: n  3
hours). Left panel: A. saphena. Right panel: aorta.Resorufin formation is not limited to one single enzyme, put rather gives general information on the cellular redox
tate.15 For all tested conditions, no significant changes in
he tissue reductive capacity were found (Fig 3).
Vitality (LDH release) of vessels recovered after
ardiac death. Cumulative lactate dehydrogenase release
rom tissue into the storage solution is depicted in Fig 4.
aseline levels of LDH release from immediately recovered
essels were 1.4  0.3 U/mL for A. saphena and 25  5
/mL for aorta. The large difference between the two
essel types may be attributed to unequal segment mass and
he three times higher internal diameter of aorta, which can
esult in an improved diffusion into the storage solution.
ean released LDH activity of control vessels generally
ncreased with cold storage duration in A. saphena and
orta (Fig 4). For A. saphena, this trend was observed for all
nalyzed postmortem recovery time points. In aorta, in-
reasing delay of recovery after circulatory arrest increased
eleased LDH activity. The increase in released LDH dur-
ng prolonged cold storage was less obvious for vessels
ecovered 2 and 6 hours postmortem. For vessels recovered
4 hours postmortem, LDH release declined after 7 days
torage. It should be noted that these vessels did not exhibit
essel tone.
Antibiotics and vessel function of rat aorta. As
escribed above, recovery of rat aorta 2 hours after circula-
ory arrest and further cold storage for 4 days did not
ignificantly impair vessel function. These were the condi-
ions chosen to test for a potential influence of antimicro-
ial agents on vessel function. Antibiotics gentamycin,
recovered at different time points after circulatory arrest
h subsequent cold storage for various durations (2-336ssels
), witiperacillin, flucloxacillin, and metronidazole or the anti-
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Volume 54, Number 6 Ebner et al 1773mycotic amphotericin B were added to the storage solution
for 4 days. Vessel tone development was not impaired by
addition of gentamycin, piperacillin, or metronidazole or a
combination of these three substances (Fig 5). Storage with
flucloxacillin alone or in combination with other antibiotics
significantly suppressed vessel tone development. Addition
of amphotericin B to the storage solution completely abol-
ished any vessel tone development. This effect was not only
limited to norepinephrine-dependent vasoconstriction, but
receptor-independent potassium-invoked vasoconstriction
Fig 3. Reductive capacity of vessels recovered at differen
hours: n  5; 24 hours: n  3), with subsequent cold
saphena. Right panel: aorta. pm, Postmortem.
Fig 4. Cumulative lactate dehydrogenase (LDH) activit
at indicated time points after circulatory arrest (0 hours, 2
storage was 2 to 336 hours. Left panel: A. saphena. Rigwas completely abolished as well (Fig S5, online only). Due To the lack of vessel tone development, relaxation parame-
ers could not be assessed for vessel segments stored with
ddition of amphotericin B.
All other additives, including flucloxacillin, despite its
ffects on vessel tone development, did not significantly
nfluence endothelium-dependent and -independent vas-
relaxation, and the values obtained for maximum relax-
tion were similar to those obtained in the study with
essels recovered at different time points postmortem.
Antibiotics and vessel function of rat A. saphena.
e points after circulatory arrest (0 hours, 2 hours, and 6
ge for various durations (2-336 hours). Left panel: A.
ase in cold storage supernatant. Vessels were recovered
s, and 6 hours: n 5; 24 hours: n 3). Subsequent cold
nel: aorta. pm, Postmortem.t tim
storay rele
hourhe effect of antibiotics as additives to cold storage solution
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December 20111774 Ebner et alon A. saphena vessel function was assessed in “non-damaged
vessels” recovered immediately after circulatory arrest and
in “pre-damaged vessels” recovered 6 hours postmortem.
For both conditions, vessel tone development remained
stable during 1-week storage period with and without the
addition of an antibiotic cocktail containing gentamycin,
piperacillin, metronidazole, and flucloxacillin (Fig 6, left
panel). Addition of amphotericin B to the storage solution
abolished any vessel tone development, and these vessels
Fig 5. Vessel tone development of aortae recovered 2 ho
was performed without (n  8) and with addition of dif
Stored 96 hours with addition of flucloxacillin.G: Store
with addition of piperacillin.M: Stored 96 hours with a
of amphotericin B.
Fig 6. Vessel tone development (left panel) and endo
saphena. Following recovery of vessels either without dela
they were stored at 4°C in storage buffer with and with
each). 7d  FGMP: 7 days cold storage with addition o
7d  AFGMP: 7 days cold storage with addition of
amphotericin B. pm, Postmortem.were excluded from relaxation analysis. In contrast, smooth puscle dilatative function was not impaired by storage with
ntibiotics (Fig S4, online only).
In the vessels recovered immediately, there was no
mpairment of endothelium-dependent relaxation fol-
owing storage for 7 days with or without addition of
ntibiotics (Fig 6, right panel). As reported above (Fig
), A. saphena recovered 6 hours postmortem and stored
or 7 days without further additives showed a signifi-
antly lower endothelium-dependent relaxation com-
fter circulatory arrest. The following cold storage at 4°C
t antimicrobial substances (n  4 each) as follows. F:
hours with addition of gentamycin.P: Stored 96 hours
n of metronidazole.A: Stored 96 hours with addition
m-dependent relaxation response (right panel) of A.
ck bars) or 6 hours after circulatory arrest (hatched bars),
dition of different antibiotics and antimycotics (n  5
loxacillin, gentamycin, piperacillin, and metronidazole.
xacillin, gentamycin, piperacillin, and metronidazole,urs a
feren
d 96
dditiotheliu
y (bla
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flucloared with cold storage control. This was also true for
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Volume 54, Number 6 Ebner et al 1775vessels stored with addition of antibiotics to the cold
storage solution.
To further elucidate the extent of damage, reductive
capacity measurements and quantification of LDH release
were performed (Fig 7). Reductive capacity of A. saphena
stored with and without gentamycin, piperacillin, metroni-
dazole, and flucloxacillin was similar for vessels recovered
immediately postmortem and those recovered 6 hours
later. Addition of amphotericin B to the storage solution
resulted in a statistically significant decrease of reductive
capacity for both conditions of vessel recovery. As expected,
LDH release was significantly increased following cold
storage for 1 week compared with 2 hours for both recovery
conditions (Fig 7, right panel). Surprisingly, this was not
true for vessels stored for 1 week with addition of antimi-
crobial agents. Antibiotic mixtures with and without am-
photericin B showed a cumulative LDH activity release
similar to the cold storage control. To exclude an effect of
the antibiotics used on assay performance, in vitro activity
of isolated LDH was tested in presence of each substance.
None of the compounds diminished the LDH activity (data
not shown).
DISCUSSION
The findings of the present study suggest that the use of
vessels obtained from donors after cardiac death for allo-
transplantation is feasible. It has been described that vari-
ous processes disturbing vessel integrity, like elastic fiber
separation/rupture or smooth muscle cell shrinking, pro-
ceed with prolonged warm ischemia.16 Additionally endo-
thelial cell function is impaired, which can lead to enhanced
leukocyte adhesion.17 Therefore, the current study at-
Fig 7. Reductive capacity (left panel) and released LDH
vessels either without delay (black bars) or 6 hours after c
and without addition of different antibiotics and antimy
addition of flucloxacillin, gentamycin, piperacillin, andme
of flucloxacillin, gentamycin, piperacillin, and metronidatempted to address potential detrimental effects of warm uschemia by studying different delays of postmortem sam-
ling in combination with standardized cold storage
t 4°C.
In our rat model, vessels recovered 2 hours after circu-
atory arrest did not differ with respect to vessel function
arameters compared with immediately recovered controls.
owever, this time span may vary between different spe-
ies. Vessels recovered 6 hours or later postmortem showed
significantly reduced receptor-mediated vessel tone de-
elopment. Norepinephrine activates preferentially vessel -
drenoreceptors and a downstream signaling cascade, leading
o a calcium-influx, which results in vessel contraction.18
ecause not only receptor-mediated contraction but also
otassium-induced contraction was impaired, this is un-
ikely to mirror exclusively disorders in the adrenoreceptor
ystem. Vessel tone development is an important measure
or overall vessel function and should not be confused with
ypercontractility or vasospasms, which can lead to isch-
mia of downstream areas.19 In our experimental setup, a
educed vessel tone may reflect disorders of the calcium
obilization and storage 20 or an altered response of mem-
rane channels. Alternatively, the contractile system21 or
he integrity of the elastic fiber may be impaired.22 It was
eyond the scope of this study to differentiate between
hese molecular causes for reduced vessel tone develop-
ent. Further studies are needed to clarify the underlying
echanisms.
The second aim of our study was to investigate whether
essels recovered from donors after cardiac death are more
ensitive toward cold storage damage. These experiments
ere performed, because first, additional storage for 1 week
s requested for microbial testing, and second, vessels are
ivity (right panel) of A. saphena. Following recovery of
atory arrest (hatched bars), they were stored at 4°C with
s (n  5 each). 7d  FGMP: 7 days cold storage with
idazole. 7dAFGMP: 7 days cold storage with addition
amphotericin B. pm, Postmortem.act
ircul
cotic
tronsually stored for at least 24 hours for decontamination
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December 20111776 Ebner et alprior to cryopreservation of grafts. Cryopreservation as an
alternative to cold storage of vessels is known to largely
destroy endothelial integrity23 and was not considered in
the current study.
We found that it is feasible to preserve function of
vessels recovered 2 hours after circulatory arrest when an
optimized storage solution is used. A. saphena recovered 6
hours after circulatory arrest is more sensitive to cold stor-
age damage than vessels recovered earlier. When vessels
recovered 6 hours postmortem are stored for 4 days or
longer at 4°C, a significant impairment of endothelium-
dependent relaxation was found. This indicates endothelial
dysfunction.24 This finding is important, because endothe-
lial injury which occurs during the storage period may
initiate pathologic processes influencing later graft patency.
The phenomenon of graft vasculopathy is widely known
and has been described to be associated with later athero-
sclerosis. Endothelial dysfunction facilitates atherogenesis
in small and large vessels.25,26
As a third step, we tested whether prolonged cold
storage is feasible in the presence of antimicrobial sub-
stances and whether vessels recovered several hours after
circulatory arrest were more sensitive toward antimicrobial
treatment. Various different decontamination solutions are
used in vessel banking. However, despite these different
protocols, the tissue banks report good decontamination
results and acceptable durability of their final product.7 We
used the standard antimicrobial treatment protocol of the
German Society for Tissue Transplantation. As most graft
infections are caused by staphylococci,6,7 this is one of the
major targets of the cocktail by using gentamycin, pipera-
cillin, and flucloxacillin. Additionally, for targeting anaero-
bic bacteria, metronidazole is added, as well as amphoteri-
cin B as a broadband fungicide. Gentamycin, piperacillin,
and metronidazole did not impair the vessel function of
aorta recovered 2 hours postmortem. Flucloxacillin (Staph-
ylex) reduced receptor-dependent (norepinephrine re-
sponse; Fig 5) and -independent (potassium response; Fig
S4, online only) vessel tone development in aorta. How-
ever, the effect was not found in A. saphena. Thus, addi-
tional functional testing for an influence of flucloxacillin on
those human tissues, which are typically used as vessel
grafts, might be advised.
Amphotericin B (Fungizone) completely abolished
vessel tone development in response to norepinephrine and
potassium in both vessel types tested. We also found a
significant impairment of reductive capacity. Effects of am-
photericin B on the electron transport chain have been
described,27 and this effect may lead to the observed loss of
vessel tone development. There are multiple formulations
of amphotericin B available, which differ with respect to
their toxicologic side effects.28 Different antimycotics
might be an alternative.
However, because fungi are spore-forming organisms,
they are a continued risk of contamination even if appro-
priate antimycotics are added. Therefore, and because of
the severe vessel damage we observed following storage in
solutions containing amphotericin B (Figs 5-7), it might bedvised to discard infected vessels instead of adding anti-
ycotics to the storage solution, as has been suggested by
thers for different tissues.6
Taken together, in this study we demonstrate in a rat
odel that vessels recovered 2 hours after circulatory arrest
isplay vessel functions similar to vessels sampled without
ny delay. Additionally, such vessels were not more sensi-
ive toward prolonged cold storage or addition of antimi-
robial substances. However, not all antibiotic agents cur-
ently considered seem suitable for preservation of vessel
unction.
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